LMO1 Antibody
-
中文名稱：LMO1兔多克隆抗體
-
貨號：CSB-PA02055A0Rb
-
規格：￥440
-
圖片：
-
Western blot
All lanes: LMO1 antibody at 2µg/ml
Lane 1: EC109 whole cell lysate
Lane 2: 293T whole cell lysate
Secondary
Goat polyclonal to rabbit IgG at 1/15000 dilution
Predicted band size: 18 kDa
Observed band size: 50 kDa
-
-
其他：
產品詳情
-
產品名稱：Rabbit anti-Homo sapiens (Human) LMO1 Polyclonal antibody
-
Uniprot No.：
-
基因名：LMO1
-
別名：Cysteine rich protein TTG 1 antibody; Cysteine rich protein TTG1 antibody; Cysteine-rich protein TTG-1 antibody; LIM domain only 1 antibody; LIM domain only protein 1 antibody; LMO 1 antibody; LMO-1 antibody; lmo1 antibody; MGC116692 antibody; RBTN 1 antibody; RBTN1 antibody; RBTN1_HUMAN antibody; RHOM 1 antibody; RHOM1 antibody; Rhombotin 1 antibody; Rhombotin-1 antibody; Rhombotin1 antibody; T cell translocation protein 1 antibody; T-cell translocation protein 1 antibody; TTG 1 antibody; TTG1 antibody
-
宿主：Rabbit
-
反應種屬：Human
-
免疫原：Recombinant Human Rhombotin-1 protein (5-156AA)
-
免疫原種屬：Homo sapiens (Human)
-
標記方式：Non-conjugated
本頁面中的產品，LMO1 Antibody (CSB-PA02055A0Rb)，的標記方式是Non-conjugated。對于LMO1 Antibody，我們還提供其他標記。見下表：
-
克隆類型：Polyclonal
-
抗體亞型：IgG
-
純化方式：>95%, Protein G purified
-
濃度：It differs from different batches. Please contact us to confirm it.
-
保存緩沖液：Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M PBS, PH 7.4 -
產品提供形式：Liquid
-
應用范圍：ELISA, WB
-
推薦稀釋比：
Application Recommended Dilution WB 1:1000-1:5000 -
Protocols：
-
儲存條件：Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
貨期：Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.
-
用途：For Research Use Only. Not for use in diagnostic or therapeutic procedures.
產品評價
相關產品
靶點詳情
-
功能：May be involved in gene regulation within neural lineage cells potentially by direct DNA binding or by binding to other transcription factors.
-
基因功能參考文獻：
- Target genes of the LMO1-regulated microRNAs and their relevant pathways may be a potential therapeutic targe PMID: 30194082
- IKZF1 rs10235796 C allele, IKZF1 rs6964969A>G, CDKN2A rs3731246 G>C, and CDKN2A rs3731246 C allele were signi fi cantly associated with Acute Lymphoblastic Leukemia in Yemenis of Arab-Asian descent. Borderline association found in IKZF1 rs4132601 T>G variant. No associations found with LMO1 rs442264; rs3794012; rs4237770 PMID: 28768142
- These results suggested that LMO1 gene rs110419 A > G polymorphism may contribute to protection against neuroblastoma PMID: 27009839
- A C-to-T single nucleotide transition occurs as a somatic mutation in noncoding sequences 4 kb upstream of the transcriptional start site of the LMO1 oncogene in primary samples from patients with T-cell acute lymphoblastic leukaemia. This conforms to an APOBEC-like cytidine deaminase mutational signature and a new MYB binding site driving high levels of LMO1 expression. PMID: 28260788
- LMO1 is an important oncogene that promotes neuroblastoma initiation, progression, and widespread metastatic dissemination. PMID: 28867147
- LMO1 appears to be a coactivator of AR involved in the progression of prostate cancer PMID: 26459575
- data suggest that genetic variants in LMO1 are associated with increased NB risk in Chinese children. PMID: 26030754
- a polymorphism within a super-enhancer element in the first intron of LMO1 influences neuroblastoma susceptibility through differential GATA transcription factor binding and direct modulation of LMO1 expression in cis PMID: 26560027
- LMO1 is a commonly activated tumor promoter that activates AKT signaling in non-small cell lung cancer. PMID: 25037573
- LMO1 is a commonly activated tumor promoter that activates AKT signaling in colorectal cancer and a new predictive marker for targeted therapy. PMID: 24845030
- results show that LMO1 is poised for expression in normal progenitors, where activation of SCL/TAL1 together with a breakdown of epigenetic repression of LMO1 regulatory elements PMID: 23302769
- genetic variants within LMO1 are associated with acute lymphoblastic leukemia and identify this gene as a strong candidate for precursor B-cell leukemogenesis. PMID: 21602560
- data show that common polymorphisms at the LMO1 locus are strongly associated with susceptibility to developing neuroblastoma, but also may influence the likelihood of further somatic alterations at this locus, leading to malignant progression PMID: 21124317
- 60% of transgenic mice that overexpressed both OLIG2 and LMO1 developed pre-T lymphoblastic lymphoma/leukemia with large thymic tumor masses. PMID: 16103065
- The present data suggest that TGF-beta, LMO1, possibly RUNX3, and GSDM form a regulatory pathway for directing the pit cells to apoptosis. PMID: 17471240
顯示更多
收起更多
-
相關疾病：A chromosomal aberration involving LMO1 may be a cause of a form of T-cell acute lymphoblastic leukemia (T-ALL). Translocation t(11,14)(p15;q11) with TCRD.
-
亞細胞定位：Nucleus.
-
組織特異性：Expressed mainly in the central nervous. Low level of expression in other tissues including thymus.
-
數據庫鏈接：
Most popular with customers
-
YWHAB Recombinant Monoclonal Antibody
Applications: ELISA, WB, IHC, IF, FC
Species Reactivity: Human, Mouse, Rat
-
Phospho-YAP1 (S127) Recombinant Monoclonal Antibody
Applications: ELISA, WB, IHC
Species Reactivity: Human
-
-
-
-
-
-
